Enovis Rides Momentum from Scaling Acquisitions

Enovis reported 1Q23 orthopedic sales of $170.5 million, +16.7% compared to the first quarter of the prior year.

The outsized growth came from receding market pressure as well as softer comps in the prior year. Envois didn't see a significant backlog contribution to its U.S. growth.

"What you saw in the U.S. was normal, healthy levels....

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Mike Evers is a Senior Market Analyst and writer with over 15 years of experience in the medical industry, spanning cardiac rhythm management, ER coding and billing, and orthopedics. He joined ORTHOWORLD in 2018, where he provides market analysis and editorial coverage.

Contact Us